2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on AML: Is Anti-CD47 Antibody Magrolimab + Azacitidine Effective and Well Tolerated in TP53-mutant AML?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Vij
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Vij
23 views
July 22, 2020
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology